1919 Investment Counsel’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

1919 Investment Counsel’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$461K	Hold	5,015	–	–	0.01%	457
2014 Q2	$413K	Hold	5,015	–	–	0.01%	462
2014 Q1	$385K	Hold	5,015	–	–	0.01%	463
2013 Q4	$347K	Sell	5,015 -435	-8%	-$28.5K	0.01%	474
2013 Q3	$354K	Hold	5,450	–	–	0.01%	459
2013 Q2	$318K	Buy	+5,450	New	+$311K	0.01%	450

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

1919 Investment Counsel's FBT Position: Q3 2014 in Review

1919 Investment Counsel held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2014 at 5,015 shares worth $461K. The position accounts for 0.01% of the portfolio, ranked #457.

1919 Investment Counsel first reported a position in FBT in Q2 2013 and has held it in 6 quarters since. 98 funds tracked by Wall St. Rank hold FBT as of Q3 2014.

1919 Investment Counsel held 5,015 shares of First Trust NYSE Arca Biotechnology Index Fund worth $461K as of Q3 2014.
1919 Investment Counsel left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2014.
First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of 1919 Investment Counsel's portfolio in Q3 2014, its #457 holding.
1919 Investment Counsel first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 6 quarters since.
98 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.